NCT05364853

Neurodevelopmental Effects of Antiseizure Medications (NEAM) - UG3 Phase

• Status: Withdrawn
• Phase: N/A
• Study type: Interventional
• Enrollment: 0 (actual)
• Sponsor: Stanford University · Academic / Other
• Sex: All
• Age: 18 Years – 55 Years
• Healthy volunteers: Not accepted

Summary

To compare in-person to remote video assessments in children to determine the reliability of remote evaluations for future neuropsychological assessments and set a precedent for future investigations.

Conditions

• Epilepsy

Interventions

Type	Name	Description
BEHAVIORAL	In-Person Testing	Participants will be randomly assigned to have either in-person testing of the DAYC-2 conducted. They will then cross over into the other testing condition approximately 3 weeks after their first assessment.
BEHAVIORAL	Remote Testing	Participants will be randomly assigned to have either remote testing of the DAYC-2 conducted. They will then cross over into the other testing condition approximately 3 weeks after their first assessment.

Timeline

• Start date: 2024-04-01
• Primary completion: 2026-03-31
• Completion: 2026-09-01
• First posted: 2022-05-06
• Last updated: 2024-08-19